Paper Title

Ciprofloxacin ocuserts: Design, Formulation and Evaluation

Article Identifiers

Registration ID: IJNRD_215311

Published ID: IJNRD2403242

DOI: Click Here to Get

Authors

Prajwal D. Shrirao , Navnath S. Rathod , Ajwita S. Kale , Nikita P. Aware , Ram S. Ghotkar

Keywords

Ciprofloxacin, ocuserts, bovine cornea, Franz diffusion cell, keratoconjunctivitis

Abstract

The main aim of the present study is to formulate an effective ocusert of Ciprofloxacin (an anti-biotic drug), which can produce a better ocular therapy against ocular bacterial infections. Conjunctivitis, keratitis, and keratoconjunctivitis are just a few examples of the eye infections that can be treated with ciprofloxacin hydrochloride, a fluoroquinolone antibiotic. By using different polymers in various ratios and combinations, including Poly Vinyl Alcohol (PVA), Hydroxy Propyl Methyl Cellulose (HPMC), Methyl Cellulose (MC), and Hydroxy Ethyl Cellulose (HEC), Ciprofloxacin Hydrochloride Ocuserts were made with the goal of extending the contact time, achieving sustained release, reducing the frequency of administration, improving patient compliance, and enhancing therapeutic efficacy. Here, I'm using hydroxyl methyl cellulose, which is 15cps grade, low viscosity methyl cellulose, and warm water soluble poly vinyl alcohol. The prepared ocuserts' physico-chemical properties were assessed for sterility testing, ocular irritation studies, moisture absorption, moisture loss, thickness, weight variation, folding endurance, and surface pH. Using a bovine cornea (semi permeable membrane) Franz diffusion cell, the in vitro drug release was investigated, and the maximum absorbance at 274 nm was checked. A zero order release formulation FB2 is sterilized by exposing UV radiation and subjected to In vivo studies. Ocular toxicity was also carried out for the formulation FB2. IR spectral observation show there is no interaction of drug with polymer which indicates the intactness of drug in formulation.

How To Cite (APA)

Prajwal D. Shrirao, Navnath S. Rathod, Ajwita S. Kale, Nikita P. Aware, & Ram S. Ghotkar (March-2024). Ciprofloxacin ocuserts: Design, Formulation and Evaluation. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(3), c313-c316. https://ijnrd.org/papers/IJNRD2403242.pdf

Issue

Volume 9 Issue 3, March-2024

Pages : c313-c316

Other Publication Details

Paper Reg. ID: IJNRD_215311

Published Paper Id: IJNRD2403242

Downloads: 000122002

Research Area: Pharmacy

Country: Washim, Maharashtra, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2403242.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2403242

About Publisher

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

Publication Timeline

Peer Review
Through Scholar9.com Platform

Article Preview: View Full Paper

Call For Paper

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details